SCRI Oncology Partners is a clinical research site located in Nashville, Tennessee, United States 37203.
Crixeo Clinical Trials Trust Score: 34/100 (FAILING). This profile has not yet been claimed by the site owner.
SCRI Oncology Partners has participated in 211 clinical trials with 172 currently active.
Therapeutic areas: MTAP-deleted Solid Tumors, Platinum-resistant Ovarian Cancer, Mesothelioma.
Sponsors: Bayer, Genmab, TCR2 Therapeutics.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Tennessee · View every site in Nashville
Trust Score: 34/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
SCRI Oncology Partners has a Crixeo Trust Score of 34/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
SCRI Oncology Partners has 211 clinical trials on record, with 172 currently active. Their work covers MTAP-deleted Solid Tumors, Platinum-resistant Ovarian Cancer, Mesothelioma.
SCRI Oncology Partners has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.